Voyager Therapeutics (VYGR) Tops Q1 EPS by 24c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Voyager Therapeutics (VYGR) PT Lowered to $8 at Wedbush
May 14, 2024 6:47 AM EDTWedbush analyst Laura Chico lowered the price target on Voyager Therapeutics (NASDAQ: VYGR) to $8.00 (from $10.00) while maintaining a Neutral rating.
The analyst comments "Remain Neutral rated on VYGR, new $8 target. On the heels of the AGCST meeting, the 1Q24 VYGR update... More
